Abstract CN14
Background
This study is part of the implementation of m-Health in outpatient Clinical Pharmacy at Hospital of the Principality of Andorra, with the aim of knowing the qualification of the Abeona Health App by the patient when using it for three months. The main objectives are: 1. Determine the general rating of the App according to the patient. 2 and 3. Know if the patient would continue using the App for one year and if they would recommend the App.
Methods
Cross-sectional study in onco-haematological patients under treatment with OAAs. 1. Inclusion criteria: all adult patients treated with OAAs seen from November 2022 to May 2023 (6 months of study). 2. Tool measure: the validated spanish translation of uMars survey was chosen to meet the research objectives. 3. Data collected from the patients: age, sex, type of tumour and type of OAAs. 4. Data collected from the surveys: the uMARS questions that were used to evaluate the Abeona Health App were: 2.4, 5, 6, 7, 8, 9, 10, 11, 12, 17, 18, and 20. 5. Statistical analysis: descriptive, performed with the Jamovi statistical package. 6. Ethical aspects: before providing the surveys, the patients were informed that their data would be treated anonymously, and they gave their signed informed consent to participate.
Results
64 patients were visited. 44 participated in the study (4 of them through their children for not knowing how to use an App). 41 were women (64%) and 23 men (36%) with a mean age of 63 years. The most frequent tumor in women was the breast with OAAs Palbocilic and in men the Colon with Capecitabine. The general quality of the App according to the patient's response in the uMars survey was: 7.7% of the patients scored 3, 50% scored 4 and 42.3% scored 5. When referring to the use of the App for a year, 19.2% of the patients responded from 3 to 10 times, 46.2% from 10 to 50 times, and 34.6% more than 50 times. In relation to whether patients would recommend the App, 30.8% of the patients answered that they would recommend it to many people and 69.2% that they would recommend it to everyone.
Conclusions
1. The Abeona Health App was rated with a score of more than 4 for 92.3% of patients. 2. The 80.8% of patients would continue using it for a year. 3. The 100% of patients would recommend it to people who could benefit from it.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN65 - Assessment of fatigue in elderly hospitalized cancer patients undergoing chemotherapy: A pilot study
Presenter: Maria Lavdaniti
Session: Poster session 25
Resources:
Abstract
CN66 - Cancer symptom clusters, nutritional status and quality of life of patients with cancer undergoing outpatient chemotherapy
Presenter: Luis Carlos Lopes-Júnior
Session: Poster session 25
Resources:
Abstract
CN67 - Comparison of existing guidelines for healthcare professionals on the perceived symptoms of breast cancer patients with registered symptoms in the medical records: Preliminary results
Presenter: Trine Lund-Jacobsen
Session: Poster session 25
Resources:
Abstract
CN68 - Experiences and needs of rectal cancer survivors without or with minor low anterior resection syndrome
Presenter: Fien Serroyen
Session: Poster session 25
Resources:
Abstract
CN69 - Experiences of patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A qualitative study
Presenter: Jill Dobbelaer
Session: Poster session 25
Resources:
Abstract
CN70 - Out of hours symptom triage and supportive care
Presenter: Kate Mckendry
Session: Poster session 25
Resources:
Abstract
CN71 - SensiEx: A randomized pilot trial Sensorimotor training using whole body vibration exercise to reduce chemotherapy-induced peripheral neuropathy after treatment for breast cancer
Presenter: Malin Backman
Session: Poster session 25
Resources:
Abstract
CN72 - Symptom burden, quality of life and emotional status of patients with advanced lung cancer seen at the functional lung unit
Presenter: Isabel Brao Perez
Session: Poster session 25
Resources:
Abstract
CN73 - Symptom management in patients with chemotherapy-induced hand-foot syndrome: A qualitative study
Presenter: jie Zhang
Session: Poster session 25
Resources:
Abstract
CN74 - The effect of nursing senior's self-efficacy on symptom management in cancer patients on clinical decision-making skills
Presenter: Sevinç kutlutürkan
Session: Poster session 25
Resources:
Abstract